IMACTIS INC.

IMACTIS INC. specializes in the design, integration, and deployment of advanced CT navigation imaging systems for clinical and diagnostic environments. The company’s core capabilities center on electromedical device engineering and diagnostic imaging infrastructure, with demonstrated expertise in developing precision-guided imaging platforms that enhance procedural accuracy in radiology and interventional settings. Their technical focus includes image registration algorithms, real-time spatial tracking, and seamless integration of CT data with procedural navigation software—enabling clinicians to perform minimally invasive interventions with heightened safety and efficacy. IMACTIS differentiates itself through its ability to bridge medical imaging hardware with clinical workflow software, delivering turnkey solutions tailored to high-acuity healthcare settings. The company maintains a strong, focused relationship with the Department of Veterans Affairs, consistently delivering mission-critical imaging and navigation technologies to support veteran healthcare delivery. Their engagements with VA reflect a pattern of deploying specialized diagnostic systems that improve diagnostic confidence and reduce procedural time in VA medical centers, particularly in areas requiring advanced image-guided interventions. IMACTIS operates primarily within the diagnostic imaging centers and electromedical apparatus manufacturing sectors, translating complex engineering into clinically validated tools used in radiology departments. Their market positioning is that of a niche developer of integrated imaging navigation systems, serving the intersection of medical device innovation and clinical imaging infrastructure. As a small business structured as a 2L entity based in Cambridge, Massachusetts, IMACTIS operates with agility and technical precision. While currently holding no formal government certifications, the company’s geographic proximity to leading academic and medical research institutions enhances its capacity for innovation in medical imaging technology. Their government market presence is defined by targeted, high-impact deployments within federal healthcare systems.